secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANGIODYNAMICS INC (ANGO)
CIK:        0001275187
Form:       8-K
Filed at:   2022-08-10T23:59:59+00:00
Accession:  0000914121-22-004074
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AngioDynamics CFO presents at Canaccord conference; no new material disclosures in truncated exhibit
--------------------------------------------------------------------------------

- Stephen Trowbridge, EVP & CFO, presented at Canaccord Genuity 42nd Annual Growth Conference on August 10, 2022.
- Presentation slides were furnished as Exhibit 99.1 but contain no specific financial data or updated guidance in the available text.
- Filing includes standard forward-looking statements and risk factors; no earnings results or material events disclosed.
- Exhibit text is truncated; no concrete numbers, targets, or strategic updates can be extracted from the provided portion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1275187/000091412122004074/0000914121-22-004074-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1275187/000091412122004074/an58117803-8ki.htm
  HTML page:      https://secwatch.observer/filing/0000914121-22-004074

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer